Document is current
Any future updates will be listed below
-
Authors
Fatania, Kavi https://orcid.org/0000-0003-2421-1083
Frood, Russell
Mistry, Hitesh
Short, Susan C.
O’Connor, James
Scarsbrook, Andrew F.
Currie, Stuart
-
Funding
Funding for this research was provided by:
Cancer Research UK (RadNet; C19942/A28832)
Wellcome Trust (203914/Z/16/Z)
Leeds Hospitals Charity (9R01/1403)
Cancer Research UK (C19221/A22746)
- License Information
-
More Information
Article History
Received: 17 June 2024
Revised: 12 August 2024
Accepted: 30 September 2024
First Online: 28 November 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Stuart Currie.
: A.F.S. is a member of the Scientific Editorial Board (section: nuclear medicine and molecular imaging) of European Radiology. They have not taken part in the review or selection processes of this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: One of the authors has significant statistical expertise. H.M. is a career statistician.
: Written informed consent was waived by the Institutional Review Board due to the retrospective nature of the study.
: Institutional Review Board approval was obtained. Ethical approval and institutional data access were approved via the local ethical review committee (REC ref: /YH/0300, IRAS project ID: 255585).
: Some study subjects have been previously reported in: Currie et al []. Imaging spectrum of the developing glioblastoma: a cross-sectional observation study. Current Oncology. 30(7):6682–6698. Fatania et al []. The current study focuses on radiomics modelling, intensity standardisation of MRI, and radiomic feature realignment with ComBat. None of these were investigated in the above publications.
:
